Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥750 32 36 32 36 O
cells 37 42 37 42 I-lower_bound
/ 42 43 42 43 I-lower_bound
mm3 43 46 43 46 I-lower_bound
( 47 48 47 48 O
1.0 48 51 48 51 B-lower_bound
x 52 53 52 53 I-lower_bound
109 54 57 54 57 I-lower_bound
/ 57 58 57 58 I-lower_bound
L 58 59 58 59 I-lower_bound
) 59 60 59 60 O

Creatinine 0 10 61 71 B-clinical_variable
clearance 11 20 72 81 I-clinical_variable
≥ 21 22 82 83 O
45 23 25 84 86 B-upper_bound
cc 26 28 87 89 I-upper_bound
/ 28 29 89 90 I-upper_bound
min 29 32 90 93 I-upper_bound

Female 0 6 94 100 B-gender
subject 7 14 101 108 I-gender
who 15 18 109 112 O
is 19 21 113 115 O
pregnant 22 30 116 124 B-pregnancy

Hemoglobin 0 10 125 135 B-clinical_variable
≥ 11 12 136 137 O
7 13 14 138 139 B-lower_bound
g 15 16 140 141 I-lower_bound
/ 16 17 141 142 I-lower_bound
dL 17 19 142 144 I-lower_bound

Patients 0 8 145 153 O
may 9 12 154 157 O
have 13 17 158 162 O
received 18 26 163 171 O
prior 27 32 172 177 B-treatment
adjuvant 33 41 178 186 I-treatment
antiresorptive 42 56 187 201 I-treatment
therapy 57 64 202 209 I-treatment
( 65 66 210 211 O
i.e. 66 70 211 215 O
, 70 71 215 216 O
pamidronate 72 83 217 228 B-treatment
or 84 86 229 231 O
zoledronic 87 97 232 242 B-treatment
acid 98 102 243 247 I-treatment
) 102 103 247 248 O
as 104 106 249 251 O
routine 107 114 252 259 O
care 115 119 260 264 O
, 119 120 264 265 O
or 121 123 266 268 O
radiation 124 133 269 278 B-treatment
therapy 134 141 279 286 I-treatment
as 142 144 287 289 O
palliation 145 155 290 300 O
for 156 159 301 304 O
pain 160 164 305 309 O
and/or 165 171 310 316 O
spinal 172 178 317 323 O
cord 179 183 324 328 O
compression 184 195 329 340 O

Platelet 0 8 341 349 B-clinical_variable
count 9 14 350 355 I-clinical_variable
≥ 15 16 356 357 O
30,000 17 23 358 364 B-lower_bound
/ 23 24 364 365 I-lower_bound
mm3 24 27 365 368 I-lower_bound
( 28 29 369 370 I-lower_bound
75 29 31 370 372 I-lower_bound
x 32 33 373 374 I-lower_bound
109 34 37 375 378 I-lower_bound
/ 37 38 378 379 I-lower_bound
L 38 39 379 380 I-lower_bound
) 39 40 380 381 I-lower_bound

Serum 0 5 382 387 B-clinical_variable
SGOT 6 10 388 392 I-clinical_variable
/ 10 11 392 393 I-clinical_variable
AST 11 14 393 396 I-clinical_variable
< 15 16 397 398 O
3.0 16 19 398 401 B-upper_bound
x 20 21 402 403 I-upper_bound
upper 22 27 404 409 I-upper_bound
limits 28 34 410 416 I-upper_bound
of 35 37 417 419 I-upper_bound
normal 38 44 420 426 I-upper_bound
( 45 46 427 428 I-upper_bound
ULN 46 49 428 431 I-upper_bound
) 49 50 431 432 I-upper_bound

Serum 0 5 433 438 B-clinical_variable
SGPT 6 10 439 443 I-clinical_variable
/ 10 11 443 444 I-clinical_variable
ALT 11 14 444 447 I-clinical_variable
< 15 16 448 449 O
3.0 16 19 449 452 B-upper_bound
x 20 21 453 454 I-upper_bound
upper 22 27 455 460 I-upper_bound
limits 28 34 461 467 I-upper_bound
of 35 37 468 470 I-upper_bound
normal 38 44 471 477 I-upper_bound
( 45 46 478 479 I-upper_bound
ULN 46 49 479 482 I-upper_bound
) 49 50 482 483 I-upper_bound

Serum 0 5 484 489 B-clinical_variable
total 6 11 490 495 I-clinical_variable
bilirubin 12 21 496 505 I-clinical_variable
< 22 23 506 507 O
2.0 23 26 507 510 B-upper_bound
mg 27 29 511 513 I-upper_bound
/ 29 30 513 514 I-upper_bound
dL 30 32 514 516 I-upper_bound
( 33 34 517 518 I-upper_bound
34 34 36 518 520 I-upper_bound
µmol 37 41 521 525 I-upper_bound
/ 41 42 525 526 I-upper_bound
L 42 43 526 527 I-upper_bound
) 43 44 527 528 I-upper_bound

Subject 0 7 529 536 O
has 8 11 537 540 O
a 12 13 541 542 O
Karnofsky 14 23 543 552 B-clinical_variable
performance 24 35 553 564 I-clinical_variable
status 36 42 565 571 I-clinical_variable
≥60 43 46 572 575 O
% 46 47 575 576 I-lower_bound
( 48 49 577 578 O
> 49 50 578 579 O
50 50 52 579 581 B-lower_bound
% 52 53 581 582 I-lower_bound
if 54 56 583 585 O
due 57 60 586 589 O
to 61 63 590 592 O
bony 64 68 593 597 O
involvement 69 80 598 609 O
of 81 83 610 612 O
myeloma 84 91 613 620 B-cancer
( 92 93 621 622 O
see 93 96 622 625 O
Appendix 97 105 626 634 O
IV 106 108 635 637 O
) 108 109 637 638 O

Subject 0 7 639 646 O
has 8 11 647 650 O
a 12 13 651 652 O
history 14 21 653 660 O
of 22 24 661 663 O
thromboembolic 25 39 664 678 B-chronic_disease
event 40 45 679 684 O
within 46 52 685 691 O
the 53 56 692 695 O
past 57 61 696 700 B-upper_bound
4 62 63 701 702 I-upper_bound
weeks 64 69 703 708 I-upper_bound
prior 70 75 709 714 I-upper_bound
to 76 78 715 717 O
enrollment 79 89 718 728 O

Subject 0 7 729 736 O
has 8 11 737 740 O
a 12 13 741 742 O
life 14 18 743 747 B-clinical_variable
expectancy 19 29 748 758 I-clinical_variable
≥ 30 31 759 760 O
3 32 33 761 762 B-lower_bound
months 34 40 763 769 I-lower_bound

Subject 0 7 770 777 O
has 8 11 778 781 O
a 12 13 782 783 O
prior 14 19 784 789 O
history 20 27 790 797 O
of 28 30 798 800 O
other 31 36 801 806 O
malignancies 37 49 807 819 B-cancer
unless 50 56 820 826 O
disease 57 64 827 834 O
free 65 69 835 839 O
for 70 73 840 843 O
≥ 74 75 844 845 O
5 76 77 846 847 B-lower_bound
years 78 83 848 853 I-lower_bound
, 83 84 853 854 O
except 85 91 855 861 O
for 92 95 862 865 O
basal 96 101 866 871 B-cancer
cell 102 106 872 876 I-cancer
or 107 109 877 879 O
squamous 110 118 880 888 B-cancer
cell 119 123 889 893 I-cancer
carcinoma 124 133 894 903 I-cancer
of 134 136 904 906 I-cancer
the 137 140 907 910 I-cancer
skin 141 145 911 915 I-cancer
, 145 146 915 916 O
carcinoma 147 156 917 926 B-cancer
in 157 159 927 929 I-cancer
situ 160 164 930 934 I-cancer
of 165 167 935 937 I-cancer
the 168 171 938 941 I-cancer
cervix 172 178 942 948 I-cancer
or 179 181 949 951 O
breast 182 188 952 958 B-cancer
, 188 189 958 959 O
or 190 192 960 962 O
localized 193 202 963 972 O
prostate 203 211 973 981 B-cancer
cancer 212 218 982 988 I-cancer
with 219 223 989 993 O
Gleason 224 231 994 1001 B-clinical_variable
score 232 237 1002 1007 I-clinical_variable
< 238 239 1008 1009 O
7 240 241 1010 1011 B-upper_bound
with 242 246 1012 1016 O
stable 247 253 1017 1023 O
prostate 254 262 1024 1032 B-clinical_variable
specific 263 271 1033 1041 I-clinical_variable
antigen 272 279 1042 1049 I-clinical_variable
( 280 281 1050 1051 I-clinical_variable
PSA 281 284 1051 1054 I-clinical_variable
) 284 285 1054 1055 I-clinical_variable
levels 286 292 1056 1062 I-clinical_variable

Subject 0 7 1063 1070 O
has 8 11 1071 1074 O
active 12 18 1075 1081 B-chronic_disease
viral 19 24 1082 1087 I-chronic_disease
or 25 27 1088 1090 O
bacterial 28 37 1091 1100 B-chronic_disease
infections 38 48 1101 1111 I-chronic_disease
or 49 51 1112 1114 O
any 52 55 1115 1118 O
coexisting 56 66 1119 1129 O
medical 67 74 1130 1137 O
problem 75 82 1138 1145 O
that 83 87 1146 1150 O
would 88 93 1151 1156 O
significantly 94 107 1157 1170 O
increase 108 116 1171 1179 O
the 117 120 1180 1183 O
risks 121 126 1184 1189 O
of 127 129 1190 1192 O
this 130 134 1193 1197 O
treatment 135 144 1198 1207 B-treatment
program 145 152 1208 1215 O

Subject 0 7 1216 1223 O
has 8 11 1224 1227 O
any 12 15 1228 1231 O
clinically 16 26 1232 1242 O
significant 27 38 1243 1254 O
medical 39 46 1255 1262 O
or 47 49 1263 1265 O
psychiatric 50 61 1266 1277 B-chronic_disease
disease 62 69 1278 1285 I-chronic_disease
or 70 72 1286 1288 O
condition 73 82 1289 1298 O
that 83 87 1299 1303 O
, 87 88 1303 1304 O
in 89 91 1305 1307 O
the 92 95 1308 1311 O
Investigator 96 108 1312 1324 O
's 108 110 1324 1326 O
opinion 111 118 1327 1334 O
, 118 119 1334 1335 O
may 120 123 1336 1339 O
interfere 124 133 1340 1349 O
with 134 138 1350 1354 O
protocol 139 147 1355 1363 O
adherence 148 157 1364 1373 O
or 158 160 1374 1376 O
a 161 162 1377 1378 O
subject 163 170 1379 1386 O
's 170 172 1386 1388 O
ability 173 180 1389 1396 O
to 181 183 1397 1399 O
give 184 188 1400 1404 O
informed 189 197 1405 1413 O
consent 198 205 1414 1421 O

Subject 0 7 1422 1429 O
has 8 11 1430 1433 O
had 12 15 1434 1437 O
myocardial 16 26 1438 1448 B-chronic_disease
infarction 27 37 1449 1459 I-chronic_disease
within 38 44 1460 1466 O
6 45 46 1467 1468 B-upper_bound
months 47 53 1469 1475 I-upper_bound
prior 54 59 1476 1481 I-upper_bound
to 60 62 1482 1484 O
enrollment 63 73 1485 1495 O
, 74 75 1496 1497 O
or 76 78 1498 1500 O
NYHA(New 79 87 1501 1509 B-clinical_variable
York 88 92 1510 1514 I-clinical_variable
Hospital 93 101 1515 1523 I-clinical_variable
Association 102 113 1524 1535 I-clinical_variable
) 113 114 1535 1536 I-clinical_variable
Class 115 120 1537 1542 B-lower_bound
III 121 124 1543 1546 I-lower_bound
or 125 127 1547 1549 O
IV 128 130 1550 1552 B-upper_bound
heart 131 136 1553 1558 B-chronic_disease
failure 137 144 1559 1566 I-chronic_disease
( 145 146 1567 1568 O
see 146 149 1568 1571 O
APPENDIX 150 158 1572 1580 O
VI 159 161 1581 1583 O
) 161 162 1583 1584 O
, 162 163 1584 1585 O
Ejection 164 172 1586 1594 B-clinical_variable
Fraction 173 181 1595 1603 I-clinical_variable
< 182 183 1604 1605 O
35 184 186 1606 1608 B-upper_bound
% 186 187 1608 1609 I-upper_bound
, 187 188 1609 1610 O
uncontrolled 189 201 1611 1623 B-chronic_disease
angina 202 208 1624 1630 I-chronic_disease
, 208 209 1630 1631 O
severe 210 216 1632 1638 O
uncontrolled 217 229 1639 1651 O
ventricular 230 241 1652 1663 B-chronic_disease
arrhythmias 242 253 1664 1675 I-chronic_disease
, 253 254 1675 1676 O
electrocardiographic 255 275 1677 1697 O
evidence 276 284 1698 1706 O
of 285 287 1707 1709 O
acute 288 293 1710 1715 O
ischemia 294 302 1716 1724 B-chronic_disease
or 303 305 1725 1727 O
active 306 312 1728 1734 O
conduction 313 323 1735 1745 O
system 324 330 1746 1752 O
abnormalities 331 344 1753 1766 O

Subject 0 7 1767 1774 O
has 8 11 1775 1778 O
histologically 12 26 1779 1793 O
confirmed 27 36 1794 1803 O
multiple 37 45 1804 1812 B-cancer
myeloma 46 53 1813 1820 I-cancer
that 54 58 1821 1825 O
has 59 62 1826 1829 O
never 63 68 1830 1835 O
before 69 75 1836 1842 O
been 76 80 1843 1847 O
treated 81 88 1848 1855 O

Subject 0 7 1856 1863 O
has 8 11 1864 1867 O
immeasurable 12 24 1868 1880 O
MM 25 27 1881 1883 B-cancer
( 28 29 1884 1885 O
no 29 31 1885 1887 O
measurable 32 42 1888 1898 O
monoclonal 43 53 1899 1909 O
protein 54 61 1910 1917 O
, 61 62 1917 1918 O
free 63 67 1919 1923 O
light 68 73 1924 1929 O
chains 74 80 1930 1936 O
in 81 83 1937 1939 O
blood 84 89 1940 1945 O
or 90 92 1946 1948 O
urine 93 98 1949 1954 O
, 98 99 1954 1955 O
or 100 102 1956 1958 O
measureable 103 114 1959 1970 O
plasmacytoma 115 127 1971 1983 B-cancer
on 128 130 1984 1986 O
radiologic 131 141 1987 1997 B-treatment
scanning 142 150 1998 2006 I-treatment
) 150 151 2006 2007 O

Subject 0 7 2008 2015 O
has 8 11 2016 2019 O
known 12 17 2020 2025 O
HIV 18 21 2026 2029 B-chronic_disease
infection 22 31 2030 2039 I-chronic_disease

Subject 0 7 2040 2047 O
has 8 11 2048 2051 O
known 12 17 2052 2057 O
active 18 24 2058 2064 O
hepatitis 25 34 2065 2074 B-chronic_disease
B 35 36 2075 2076 I-chronic_disease
or 37 39 2077 2079 O
hepatitis 40 49 2080 2089 B-chronic_disease
C 50 51 2090 2091 I-chronic_disease
infection 52 61 2092 2101 O

Subject 0 7 2102 2109 O
has 8 11 2110 2113 O
known 12 17 2114 2119 O
hypersensitivity 18 34 2120 2136 O
to 35 37 2137 2139 O
dexamethasone 38 51 2140 2153 B-allergy_name
, 51 52 2153 2154 O
clarithromycin 53 67 2155 2169 B-allergy_name
, 67 68 2169 2170 O
lenalidomide 69 81 2171 2183 B-allergy_name
, 81 82 2183 2184 O
or 83 85 2185 2187 O
thalidomide 86 97 2188 2199 B-allergy_name

Subject 0 7 2200 2207 O
has 8 11 2208 2211 O
measurable 12 22 2212 2222 O
disease 23 30 2223 2230 O
as 31 33 2231 2233 O
defined 34 41 2234 2241 O
by 42 44 2242 2244 O
> 45 46 2245 2246 O
0.5 47 50 2247 2250 B-lower_bound
g 51 52 2251 2252 I-lower_bound
/ 52 53 2252 2253 I-lower_bound
dL 53 55 2253 2255 I-lower_bound
serum 56 61 2256 2261 B-clinical_variable
monoclonal 62 72 2262 2272 I-clinical_variable
protein 73 80 2273 2280 I-clinical_variable
, 80 81 2280 2281 O
> 82 83 2282 2283 O
10 83 85 2283 2285 B-lower_bound
mg 86 88 2286 2288 I-lower_bound
/ 88 89 2288 2289 I-lower_bound
dL 89 91 2289 2291 I-lower_bound
involved 92 100 2292 2300 O
serum 101 106 2301 2306 B-clinical_variable
free 107 111 2307 2311 I-clinical_variable
light 112 117 2312 2317 I-clinical_variable
chain 118 123 2318 2323 I-clinical_variable
( 124 125 2324 2325 O
either 125 131 2325 2331 O
kappa 132 137 2332 2337 O
or 138 140 2338 2340 O
lambda 141 147 2341 2347 O
) 147 148 2347 2348 O
provided 149 157 2349 2357 O
that 158 162 2358 2362 O
the 163 166 2363 2366 O
serum 167 172 2367 2372 B-clinical_variable
free 173 177 2373 2377 I-clinical_variable
light 178 183 2378 2383 I-clinical_variable
chain 184 189 2384 2389 I-clinical_variable
ratio 190 195 2390 2395 I-clinical_variable
is 196 198 2396 2398 O
abnormal 199 207 2399 2407 O
, 207 208 2407 2408 O
> 209 210 2409 2410 O
0.2 210 213 2410 2413 B-lower_bound
g/24 214 218 2414 2418 I-lower_bound
hrs 219 222 2419 2422 I-lower_bound
urinary 223 230 2423 2430 O
M 231 232 2431 2432 O
- 232 233 2432 2433 O
protein 233 240 2433 2440 O
excretion 241 250 2441 2450 O
, 250 251 2450 2451 O
and/or 252 258 2452 2458 O
measurable 259 269 2459 2469 O
plasmacytoma(s 270 284 2470 2484 B-cancer
) 284 285 2484 2485 I-cancer
of 286 288 2486 2488 O
at 289 291 2489 2491 O
least 292 297 2492 2497 O
1 298 299 2498 2499 B-lower_bound
cm 299 301 2499 2501 I-lower_bound
in 302 304 2502 2504 O
greatest 305 313 2505 2513 O
dimension 314 323 2514 2523 O
as 324 326 2524 2526 O
measured 327 335 2527 2535 O
by 336 338 2536 2538 O
either 339 345 2539 2545 O
CT 346 348 2546 2548 B-treatment
scanning 349 357 2549 2557 I-treatment
or 358 360 2558 2560 O
MRI 361 364 2561 2564 B-treatment

Subject 0 7 2565 2572 O
has 8 11 2573 2576 O
no 12 14 2577 2579 O
prior 15 20 2580 2585 B-treatment
anti 21 25 2586 2590 I-treatment
- 25 26 2590 2591 I-treatment
myeloma 26 33 2591 2598 I-treatment
treatment 34 43 2599 2608 I-treatment
therapy 44 51 2609 2616 I-treatment
within 52 58 2617 2623 O
14 59 61 2624 2626 B-upper_bound
days 62 66 2627 2631 I-upper_bound
prior 67 72 2632 2637 I-upper_bound
to 73 75 2638 2640 O
initiation 76 86 2641 2651 O
of 87 89 2652 2654 O
study 90 95 2655 2660 B-treatment
treatment 96 105 2661 2670 I-treatment
except 106 112 2671 2677 O
for 113 116 2678 2681 O
corticosteroids 117 132 2682 2697 B-treatment
with 133 137 2698 2702 O
a 138 139 2703 2704 O
maximum 140 147 2705 2712 O
allowed 148 155 2713 2720 O
dosage 156 162 2721 2727 O
equivalent 163 173 2728 2738 O
to 174 176 2739 2741 O
three 177 182 2742 2747 B-upper_bound
pulses 183 189 2748 2754 O
of 190 192 2755 2757 O
dexamethasone 193 206 2758 2771 B-treatment
( 207 208 2772 2773 O
40 208 210 2773 2775 O
mg 210 212 2775 2777 O
daily 213 218 2778 2783 O
for 219 222 2784 2787 O
4 223 224 2788 2789 O
days 225 229 2790 2794 O
equals 230 236 2795 2801 O
one 237 240 2802 2805 O
pulse 241 246 2806 2811 O
) 246 247 2811 2812 O

Subject 0 7 2813 2820 O
has 8 11 2821 2824 O
previously 12 22 2825 2835 O
been 23 27 2836 2840 O
treated 28 35 2841 2848 O
for 36 39 2849 2852 O
multiple 40 48 2853 2861 B-cancer
myeloma 49 56 2862 2869 I-cancer

Subject 0 7 2870 2877 O
is 8 10 2878 2880 O
able 11 15 2881 2885 O
to 16 18 2886 2888 O
take 19 23 2889 2893 O
prophylactic 24 36 2894 2906 B-chronic_disease
anticoagulation 37 52 2907 2922 I-chronic_disease
as 53 55 2923 2925 O
detailed 56 64 2926 2934 O
in 65 67 2935 2937 O
section 68 75 2938 2945 O
9.1 76 79 2946 2949 O
( 80 81 2950 2951 O
patients 81 89 2951 2959 O
intolerant 90 100 2960 2970 O
to 101 103 2971 2973 O
aspirin 104 111 2974 2981 B-treatment
may 112 115 2982 2985 O
use 116 119 2986 2989 O
warfarin 120 128 2990 2998 B-treatment
or 129 131 2999 3001 O
low 132 135 3002 3005 B-treatment
molecular 136 145 3006 3015 I-treatment
weight 146 152 3016 3022 I-treatment
heparin 153 160 3023 3030 I-treatment
) 160 161 3030 3031 O

Subject 0 7 3032 3039 O
is 8 10 3040 3042 O
at 11 13 3043 3045 O
least 14 19 3046 3051 O
65 20 22 3052 3054 B-lower_bound
years 23 28 3055 3060 I-lower_bound
old 29 32 3061 3064 O
at 33 35 3065 3067 O
the 36 39 3068 3071 O
time 40 44 3072 3076 O
of 45 47 3077 3079 O
signing 48 55 3080 3087 O
the 56 59 3088 3091 O
consent 60 67 3092 3099 O
form 68 72 3100 3104 O

Subject 0 7 3105 3112 O
is 8 10 3113 3115 O
unable 11 17 3116 3122 O
to 18 20 3123 3125 O
reliably 21 29 3126 3134 O
take 30 34 3135 3139 O
oral 35 39 3140 3144 B-treatment
medications 40 51 3145 3156 I-treatment

